Comparison of guidelines for biological ancillary materials used for the manufacture of gene and cellular therapy products in Asia

Cytotherapy. 2023 Feb;25(2):220-228. doi: 10.1016/j.jcyt.2022.09.005. Epub 2022 Oct 20.

Abstract

Background aims: Although biologiocal ancillay materials (AMs) have specific risk associated with their derivations, it plays key role to manufature cell and gene therapy (CGT) products. It is important to understand the regulation relevant to AMs for developers.

Methods: The authors investigated the guidelines and pharmacopeia (hereinafter referred to as "guidelines") for biological AMs used for the manufacture of CGT products in Asia (China, India, Japan, Korea and Taiwan). In addition, the authors benchmarked the relevant guidelines in the United States (US) and European Union (EU).

Results and discussions: The guidelines could be classified into two types based on whether specific AMs are scoped: (i) general guidelines for risk assessment of AMs and (ii) guidelines for specific AMs. The authors compared the risk categories for each type of AM provided in the general guidelines between the US and China and the specific requirements for bovine serum and trypsin in the guidelines of China, Japan, Taiwan, US and EU. The authors further compiled in-depth descriptions of the respective regulations in China, India, Japan, Korea and Taiwan. There is limited availability of some guidelines for specific AMs. Moreover, there are no common requirements established across the surveyed countries and regions. Therefore, the authors suggest a risk assessment approach for AMs with consideration of their biological origin and traceability, production steps applied and ability to control or remove AMs from the final medicinal product over the CGT manufacturing process.

Keywords: APACRM; Asia; ancillary materials; cell and gene therapy products; regulatory guidelines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asia
  • China
  • European Union*
  • India
  • Japan
  • United States